Mike Morrison;Dana Miller;Eric Blackstone;Mark B. Roth
发明人:
Mark B. Roth,Mike Morrison,Eric Blackstone,Dana Miller
申请号：
US13194635
公开号：
US20120040024A1
申请日:
2011.07.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
